Latest Tariff Impact News

Alcoa Corporation reported a $232 million net income in Q3 2025 despite significant restructuring costs, driven by increased alumina and aluminum production and strategic asset sales.

Tivan Limited has formalized a three-year strategic partnership with New York-based Exante Data to deepen analytics and policy advisory in the rapidly evolving critical minerals sector.

Burgundy Diamond Mines has been approved as eligible for up to CAD 150 million in emergency funding to sustain operations at its Ekati mine amid a sharp downturn in diamond prices caused by US tariffs. Trading in its securities remains suspended pending funding confirmation.

Atomos Ltd reported a 9% revenue decline in FY25, impacted by US tariffs and weak sales of new products, but has aggressively cut costs and revamped its strategy to fuel growth in FY26.

TZ Limited reported a challenging FY25 with a $3.52 million net loss, impacted by integration costs and US tariff disruptions. Despite setbacks, the company completed the Keyvision acquisition and anticipates a strong revenue rebound in FY26.

Gale Pacific’s FY25 results reveal resilience amid US market challenges, with growth in Australia and the Middle East offsetting tariff impacts and prompting a major US operating restructure.

Austco Healthcare has reported a robust FY25 with revenues climbing 40% to $81.4 million and EBITDA jumping 62% to $13 million, driven by organic growth and strategic acquisitions.

Ansell Limited reports robust FY25 growth driven by strong Industrial and Healthcare segments, completes KBU acquisition integration ahead of schedule, and announces a $200 million share buyback for FY26.

Ansell Limited reported robust FY25 results, driven by strong organic growth and the successful integration of Kimberly-Clark’s PPE business. The company also advanced its sustainability commitments and navigated tariff challenges with strategic pricing and sourcing.

Morphic Ethical Equities Fund Limited reported a strong turnaround in FY2025 with a $5.44 million net profit and portfolio returns surpassing its benchmark, while continuing aggressive share buybacks despite withholding dividends.

Fisher & Paykel Healthcare has issued strong first half FY26 guidance, forecasting significant revenue and profit growth while navigating new US tariffs. Meanwhile, director Pip Greenwood announces her retirement after eight years on the board.

Breville Group Limited reported robust FY25 results with double-digit revenue and profit growth, successfully navigating US-China tariff challenges through strategic manufacturing diversification and market expansion.